By Josh White
Date: Thursday 31 Aug 2023
(Sharecast News) - Biopharmaceutical developer Ovoca Bio's shares were plummeting on Thursday, after it released a summary of the top-line results from its phase two dose-ranging study evaluating Orenetide.
By Josh White
Date: Wednesday 08 Mar 2023
(Sharecast News) - Biopharmaceutical company Ovoca Bio announced on Wednesday that it will be disposing of certain Russian assets to the private Russian company Desirix.
By Josh White
Date: Friday 29 Jul 2022
(Sharecast News) - Women's health-focussed biopharmaceutical company Ovoca Bio announced the successful completion of participant enrollment in a phase 2 dose-ranging study assessing 'orenetide' on Friday.
Currency | UK Pounds |
Share Price | 0.85p |
Change Today | -0.050p |
% Change | -5.56 % |
52 Week High | 14.00 |
52 Week Low | 0.55 |
Volume | 206,615 |
Shares Issued | 88.46m |
Market Cap | £0.75m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
11:35 | 200,000 @ 0.82p |
08:42 | 6,615 @ 0.96p |
CEO | Kirill Andreyevich Golovanov |
You are here: research